Long-Acting Injectables Policy Papers BACK TO LAIS MAIN POLICY PAGEHIV LONG-ACTING INJECTABLES: Patient Access Considerations for Injectable HIV Therapies & Injectable HIV Pre-Exposure Prophylaxis (June 2024)Executive Summary (2-pages)HIV LONG-ACTING AGENTS: Policy Considerations for Injectable Therapies under the Ryan White HIV/AIDS Program & State AIDS Drug Assistance Programs (August 2022)Cover Letter - "The Future is Now – Welcome to the Age of Injectables"Executive Summary (2-pages)BACK TO LAIS MAIN POLICY PAGE
